Explore a rare case of systemic mastocytosis in a young adult, highlighting its role in unexplained osteoporosis and the need ...

Systemic Mastocytosis with an Associated Hematologic Neoplasm SM-AHN is a rare subtype in which systemic mastocytosis coexists with another health condition, such as acute myeloid leukemia (AML ...

—In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants progressed to an advanced form of SM, incurring greater healthcare costs along ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In a study of 116 patients with systemic mastocytosis (SM), a rare mast cell disease, about 1 in 5 participants ...

Systemic mastocytosis is a rare blood disorder in which too many mast cells accumulate in various parts of the body. Advanced forms of systemic mastocytosis have more significant symptoms and in ...

A new case report was published in Oncoscience's Volume 12 on February 4, 2025, titled “Breaking point: Systemic mastocytosis manifesting as severe osteoporosis.” ...

This report highlights the diagnostic challenges of SM, emphasize its underrecognized role in osteoporosis and fragility fractures, and advocates for ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically ...

Blueprint Medicines Corporation, a Delaware-based biopharmaceutical company, recently released its financial results for the year ended December 31, 2024, along with key business highlights. The ...